Drug Trial Radar · NCT07116733
Desflurane vs. Propofol for Cardiac Anesthesia
Last checked: Nov 19, 2026Latest source record: Nov 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,560
Planned (sponsor's estimate)
Start
Oct 20, 2025
Primary completion
Dec 31, 2028
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Xijing HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate whether the inhaled anesthetic desflurane, compared with propofol, exerts cardioprotective effects and reduces the incidence of severe postoperative major cardiac events in patients undergoing coronary artery bypass graft (CABG) surgery.
Conditions
- Cardiac Surgery
- Coronary Artery Bypass Grafting
Interventions
Desflurane groupDrug
After routine induction, maintain anesthesia with inhaled desflurane , adjusting concentration as needed to sustain 0.5-2 MAC . To maximize the cardioprotective effects of inhaled anesthetics, adhere to this intraoperative strategy: Maintain ≥1 MAC continuous desflurane for ≥30 minutes ; For on-pump CABG , discontinue desflurane 15 minutes before initiating cardiopulmonary bypass (CPB) ; If intraoperative desflurane cessation is required, implement a wash-in/wash-out strategy (recommended but non-mandatory): Perform 3 alternating cycles of: Wash-in : ≥10 minutes of desflurane at ≥0.5 MAC, Wash-out : ≥10 minutes of complete cessation of inhaled anesthetics. Propofol is strictly prohibited for anesthesia maintenance throughout the procedure , except during CPB.
Propofol groupDrug
Administer total intravenous anesthesia (TIVA) using propofol infusion at 3-8 mg/kg/h . No inhaled anesthetics are permitted for maintenance. This may be delivered via:target-controlled infusion (TCI) systems, or manual adjustment of intravenous infusion rates.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite outcome of death and major cardiac eventsTime frame: within 30 days after operation
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Daping Hospital, Army Medical University
Chongqing, China · Not yet recruiting
Changhai Hospital
Shanghai, China · Recruiting
Zhongshan Hospital, Fudan University
Shanghai, China · Not yet recruiting
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China · Not yet recruiting
Cangzhou People's Hospital
Cangzhou, Hebei, China · Not yet recruiting
Hebei General Hospital
Shijiazhuang, Hebei, China · Not yet recruiting
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Wuhan Asia Heart Hospital
Wuhan, Hubei, China · Not yet recruiting
Jiangsu Province Hospital
Nanjin, Jiangsu, China · Not yet recruiting
Xijing Hospital
Xi'an, Shaanxi, China · Recruiting
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China · Not yet recruiting
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Ningbo No.2 Hospital
Ningbo, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.